https://www.marketscreener.com/quote/stock/INSTIL-BIO-INC-120780840/news/Instil-Bio-Announces-Resumption-of-Clinical-Trial-of-Costar-Til-Candidate-Itil-306-in-Lung-Ovarian-42699987/?utm_source=telegram&utm_medium=social&utm_campaign=share